ArticleCancers2022
Development of a High-Affinity Antibody against the Tumor-Specific and Hyperactive 611-p95HER2 Isoform.
Esmaeil Dorraji et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
3 papers cite it
this papercites it
ArticleCancers2022
Esmaeil Dorraji et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.